Factors Predisposing to Inappropriate Transfers of Nursing Home Residents to Emergency Departments (FINE)

February 21, 2024 updated by: University Hospital, Toulouse

According to the data of our nursing homes (NH) research network (REHPA - Gérontopôle Toulouse, 345 nursing home in France), 13.5% of NH residents are hospitalized every 3 months or about 50% per year. These hospitalizations concern for half, transfers to emergency department (ED). Data from the literature and the PLEIAD study, conducted with 300 NH in France, confirm that intense flows between NH and ED. These studies also support the idea that these transfers to ED potentially expose some NH residents to iatrogenic complications, a risk of functional decline, an increased risk of mortality, and generate additional health costs. To transfer to ED residents who will benefit from emergency care and not to transfer to ED residents for whom this transfer generates a higher risk than the expected benefit is the goal to reach to guarantee the better quality of care for NH residents.

Inappropriate transfer to ED may be defined by the absence of somatic emergency and / or palliative care known before transferring to ED and / or the presence of advance directives of non-hospitalization in the resident's file. This is a clinical situation that could be managed by other means that the transfer to ED without loss of opportunity for the patient.

The primary objective of our study is to determine the factors predisposing NH residents to inappropriate transfer to ED.

Our hypothesis is that inappropriate transfers to the ED of NH residents are conditioned by factors accessible to interventions such as the organization of the NH care system or by improving the management of some diseases in NH. Investigators also hypothesize that the cost of inappropriate transfers to the ED is considerable. Acknowledgement of costs generated by inappropriate transfers to ED would allow policy makers to make strategic decisions to improve care system.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a retroprospective study conducted in sixteen hospitals in south-west of France. Inclusion will last one year, including 4 periods (one per season) of 7 days (24h / 24, including necessarily each day of the week). All the NH residents admitted in ED will be included. For each resident included, medical and non-medical data will be collected in 4 times: retrospectively before transfer to ED (=T0); and prospectively : at ED (= T1), in hospital services in case the patient is hospitalized (=T2) and at the patient's return to NH (=T3).

At T0 data collected will concern the NH and resident basis medical state, resident's medical state the week before transfer and resident medical state before transfer to ED.

At T3 data collected will concern the resident's return modality and his/her autonomy 7 days after his/her return

Time frame:

between T1 and T3 : mean expected duration will variate from few hours if the resident isn't hospitalized (ED visit) to an average 12.4 days, which is the average length of hospital stay of NH resident hospitalized after a transfer to ED (cf Pleiad study, Rolland 2012) plus 7 days as Investigators will collect T3's data 7 days after the NH resident's return to NH

Study Type

Observational

Enrollment (Actual)

1040

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Albi, France
        • CH d'Albi
      • Auch, France
        • CH d'Auch
      • Cahors, France
        • CH de Cahors
      • Castres, France
        • CHI Castres Mazamet
      • Foix, France
        • CH Ariège Couserans
      • Gourdon, France
        • CH de Gourdon
      • Lannemezan, France
        • CH Lannemezan
      • Lavaur, France
        • CH Lavaur
      • Lourdes, France
        • CH de Lourdes
      • Moissac, France
        • CH Castelsarrasin Moissac
      • Montauban, France
        • CH Montauban
      • Rodez, France
        • CH RODEZ
      • Saint Gaudens, France
        • CH Saint Gaudens
      • Saint Girons, France
        • CHI Val d'Ariège
      • Toulouse, France, 31059
        • Toulouse University Hospital (CHU de Toulouse)
      • Vic en Bigorre, France
        • CH de Bigorre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All patients living in Nursing Home admitted in Emergency Department of the hospitals participating in the study during the inclusion period will be included in the study.

Description

Inclusion Criteria:

  • to live in a Nursing Home
  • to be directly transferred from the NH to ED
  • to have not previously been included in FINE study

Exclusion Criteria:

  • to live in structures other than Nursing Home (i.e. sheltered housing, seniors' residences, housing homes, retirement homes, long-term care units)
  • to live in the community
  • to be transferred to ED from elsewhere than the NH
  • to have previously been included in FINE study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inappropriate transfer to ED of NH residents
Time Frame: Baseline (T1 = inclusion at ED): retro-prospectively by the group of experts

Inappropriateness of the NH residents' transfers to ED : the inappropriateness of ED transfers will be determined by the opinion of a group of experts composed of geriatricians, emergency physicians, general practitioners and pharmacists. Inappropriate transfer to ED is defined by the absence of somatic emergency and / or palliative care known before decision to transfer and / or the presence of advance directives of non-hospitalization in the resident's file. This is a clinical situation that could be managed by other means that the transition to ED without loss of opportunity for the resident. To judge the inappropriateness of the transfer to ED, the group of experts will use a rating scale of usual emergencies. Individual and independent rating divergences will lead to a concerted evaluation of the clinical situation by the group.

Analyse retro-prospectively by the group of experts.

Baseline (T1 = inclusion at ED): retro-prospectively by the group of experts

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost of the NH resident transfer to ED
Time Frame: 6 months before to 6 months after the transfer
The cost of ED transfers (i.e. appropriate and inappropriate transfers) and the direct medical costs of residents 6 months before and 6 months after the first transfer will be calculated.This work will be lead in partnership with the Regional Direction of the Medical Service of the region and the medico-economic cell of the Medical Information Department of Toulouse University Hospital
6 months before to 6 months after the transfer
Avoidability of the NH resident transfer to ED
Time Frame: Baseline (T1 = inclusion at ED)
Potentially avoidable transfers to ED: When a transfer is considered appropriate it also can be considered as potentially avoidable if adequate preventive measures were implemented. The Ambulatory Care Sensitive Diagnosis usually used in the literature will be used to characterize the transfers as potentially avoidable. When a transfer is considered inappropriate it is always considered as potentially avoidable. Analyse retro-prospectively by the group of experts.
Baseline (T1 = inclusion at ED)
NH resident's autonomy using Katz'ADL
Time Frame: Change at different time points: T0, T2 (up to 12 days,if concerned) and T3 (7 days after return to NH)
- Residents' autonomy will be assessed using Katz'ADL at the NH before transfer (T0); at the end of the hospitalization if the resident is concerned (T2), and at the resident's return to ED (T3)
Change at different time points: T0, T2 (up to 12 days,if concerned) and T3 (7 days after return to NH)
Analysis of Medical prescription, with a focus on psychotropic drug
Time Frame: Change at different time points: T1 (baseline), T2 (up to 12 days,if concerned) and T3 (7 days after return to NH)
- Medical prescriptions will be collected at inclusion (T1), at the end of the hospitalization if the resident is concerned (T2), and at the resident's return to ED (T3)
Change at different time points: T1 (baseline), T2 (up to 12 days,if concerned) and T3 (7 days after return to NH)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yves ROLLAND, MD PhD, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

July 31, 2018

Study Completion (Actual)

July 31, 2018

Study Registration Dates

First Submitted

January 8, 2016

First Submitted That Met QC Criteria

February 4, 2016

First Posted (Estimated)

February 9, 2016

Study Record Updates

Last Update Posted (Actual)

February 23, 2024

Last Update Submitted That Met QC Criteria

February 21, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC31/15/7464
  • 2015-A00723-46 (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly

Clinical Trials on Appropriateness of NH resident's transfer to ED

Subscribe